oh my gosh.....how funny are you just on here without taking a real interest in what you
give your opinion on? stocks move up and down all the time on any given day even a down
day stocks go up....even on tuesday mrvl made me money......but then again apple at a 100
is funny too.....apple will be closer to 200 not 100 in the next 12 months I like nymx
already doubled up and letting it run further....I took some profit the other day and
bought some more back on Friday and of course onxx.....yeah 80% of all biotechs are down
right???? so you know all the biotechs out there??????? come on

Last edited on: 03-03-2007 03:45 pm

I don't own any shares in biotech right now. But of those three I think Qiagen has the
biggest upside. If you get a chance listen to the conference call. 80% of biotechs are
getting killed right now, thats why i would not recommend buying any speculative names in
the middle of a correction.

gross641 your seriously holding those 3 stocks???? all of those are down big.. I like to
buy on pipelines that are going up with either big pharma funding them or licensing in
place...seriously I like to make some money from time to time...like buying 250 shares of
onxx at 11.85 in mid december 06 and cashing out last week at 27.82

I don't know buying a stock based on the terrorism play is a little long now and that
chart is a bit rough for me the terror plays like bcrx are little long in the tooth for me
nymx and incy and onxx are my plays but onxx under 22 maybe oxgn as well at these levels

You might take a look at Siga Technologies SIGA (3.81). Its SIGA-246 may be the most
advanced smallpox treatment currently in development and is now in its second phase of
human testing. The stock has held up extremely well in the market weakness, and it has a
beautiful monthly long-term chart in a strong flag pole formation. The company is
concentrating on development of pharmaceutical agents and vaccines to fight potential
biowarfare pathogens. With the current era of terrorism it's in the right place.
Importantly, Eric Rose is now the company's chairman and chief executive. He is is
currently chairman of the department of surgery at Columbia University and
surgeon-in-chief of the Columbia Presbyterian Center of New York Presbyterian
Hospital...not a light-weight. Please do your own due diligence.

another one that put a good whipping on me this past week was thld.......if onxx comes
back to 22 I'm back in

I had ency......took a whipping on that ....should have traded out at close to
seven.....bcrx....never followed and never heard of qgen I like nymx right now and incy
for the next 12 months coly might be something I buy in the next week or so if it gets
something moving

The three Biotechs that i follow are biocryst pharma (BCRX),Qiagen (QGEN) and Encysive
Pharma (ENCY). Biocryst because it is more than a bird flu play and they have other drugs
in the pipeline.Qiagen because of the bullish conference call, and growth in China with
their molecular devices. Encysive Pharma because their compettitor Myogen was bought
out.I wouldn't be buying biotechs now, wait until the market recovers.

Last edited on: 03-03-2007 01:20 pm

I own nymx and looking at coly I had onxx at 11.85 but sold it at 27 and some change might
get back in around 22 if it comes back to me

Last edited on: 03-03-2007 03:19 pm